Comparison of Electrolyte Beverages and Water as Solvents for Bowel Preparation
NCT ID: NCT06675227
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
2766 participants
INTERVENTIONAL
2024-11-11
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to test whether Electrolyte Beverages as solvents can improve the cleanness of bowel preparation and the satisfaction of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing
NCT06728839
Comparison of Split-dose and Single-dose Bowel Preparation Regimens Using Polyethylene Glycol Electrolyte(PEG)
NCT06551883
Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children
NCT01626040
Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation
NCT02979223
Efficacy of Short Time Intervals in Split-Dose Bowel Preparation of Oral Sulfate Solution for Colonoscopy
NCT06317597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To clean the colon, patients must consume several liters of bowel preparation solution in a short period before the procedure.
However, a significant number of patients experience nausea or even vomiting, preventing them from completing the recommended dose, resulting in suboptimal bowel preparation and affecting the colonoscopy process.
Therefore, the investigators have designed a protocol that uses sugar-free electrolyte beverages instead of regular drinking water as a solvent for the laxative solution. By improving the taste of the oral solution and increasing the electrolyte content, the investigators aim to enhance patient compliance with colonoscopy preparation and ultimately assess the effectiveness of bowel cleansing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drinking Water Group
This group will apply the ordinary drinking water as the solvents for 2L PEG to dissolve.
No interventions assigned to this group
Electrolyte Beverages Group
This group will apply the electrolyte beverages(Alienergy) instead of ordinary drinking water as the solvents for 2L PEG to dissolve.
electrolyte beverages
Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electrolyte beverages
Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients scheduled for outpatient colonoscopy.
3. Patients prescribed sodium phosphate or polyethylene glycol for bowel preparation.
4. Willing to participate and sign the informed consent form.
5. Age ≥18 years
6. ECOG performance status \<2
Exclusion Criteria
2. Patients requiring enema preparation.
3. Uncontrolled hypertension.
4. Patients with diabetes.
5. Pregnant patients.
6. Suspected bowel obstruction.
7. Risk of aspiration.
8. Patients with severe ulcerative colitis, gastric retention, bowel perforation, toxic colitis, or megacolon.
9. Patients with severe systemic diseases (including NYHA class 3-4 heart failure, Child-Pugh class C liver failure).
10. Patients with a known allergy to polyethylene glycol.
11. Patients with a history of major gastrointestinal surgery or any other conditions that may interfere with study outcomes or adherence.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The thirteenth people's hospital of Chonqing
UNKNOWN
Fuling people's hospital of Chongqing
UNKNOWN
Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weidong Tong
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weidong Tong, MD
Role: PRINCIPAL_INVESTIGATOR
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Army Medical Center
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022XLC05
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20240924
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.